Listed

IGC Pharma, Inc.: Form 10-K for the period ended Mar 31, 2012

Filed with the SEC on Jul 16, 2012 and accepted by EDGAR at Jul 16, 2012, 17:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2011-04-01 to 2012-03-31$4.2mus-gaap:Revenues
Cost of revenue12 months2011-04-01 to 2012-03-31$4.8mus-gaap:CostOfRevenue
Selling, general and administrative12 months2011-04-01 to 2012-03-31$4.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2011-04-01 to 2012-03-31−$7.5mus-gaap:OperatingIncomeLoss
Interest expense12 months2011-04-01 to 2012-03-31$984.0kus-gaap:InterestExpense
Income tax12 months2011-04-01 to 2012-03-31$172.8kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2011-04-01 to 2012-03-31−$7.8mus-gaap:NetIncomeLoss
Diluted EPS12 months2011-04-01 to 2012-03-31−$0.27us-gaap:EarningsPerShareDiluted
Basic EPS12 months2011-04-01 to 2012-03-31−$0.27us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2011-04-01 to 2012-03-3129,089,358 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2011-04-01 to 2012-03-31−$5.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-04-01 to 2012-03-31$5.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-03-31$562.9kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-03-31$5.2mus-gaap:AssetsCurrent
Total assetsAt period end2012-03-31$25.3mus-gaap:Assets
Current liabilitiesAt period end2012-03-31$4.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-03-31$9.4mus-gaap:Liabilities
Short-term borrowingsAt period end2012-03-31$210.0kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2012-03-31$14.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-12-001484. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.